LIST OF TABLES
TABLE 1 GENERIC DRUGS FOR MIGRAINE TREATMENT
TABLE 2 PIPELINE DRUGS FOR MIGRAINE TREATMENT
TABLE 3 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY PIPELINE ANALYSIS
TABLE 4 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TYPES OF MIGRAINE, 2018-2027 (USD MILLION)
TABLE 5 NORTH AMERICA EPISODIC IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA MIGRAINE WITH AURA IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 7 NORTH AMERICA CHRONIC IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 9 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 10 NORTH AMERICA ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 NORTH AMERICA ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 12 NORTH AMERICA NONSPECIFIC THERAPIES IN MIGRAINE TREATMENT MARKET, BY TRAETMENT, 2018-2027 (USD MILLION)
TABLE 13 NORTH AMERICA TRIPTANS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 14 NORTH AMERICA OPIATES/OPOIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA ERGOT ALKALOID IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA ANTI-NAUSEA IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 18 NORTH AMERICA ADJUNCTIVE THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY TRATMENT, 2018-2027 (USD MILLION)
TABLE 20 NORTH AMERICA PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 21 NORTH AMERICA PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 22 NORTH AMERICA ANTICONVULSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 23 NORTH AMERICA CALCITONIN GENE-RELATED PEPTIDE THERAPY IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 24 NORTH AMERICA SELECTIVE SEROTONIN RECEPTOR AGONISTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 25 NORTH AMERICA ANTIDEPRESSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 26 NORTH AMERICA NSAIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 27 NORTH AMERICA BLOOD PRESSURE-LOWERING MEDICATIONS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 28 NORTH AMERICA BETA BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 29 NORTH AMERICA CALCIUM-CHANNEL BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 30 NORTH AMERICA ANGIOTENSIN BLOCKERS: ACE-IS/ARBS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 31 NORTH AMERICA NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 32 NORTH AMERICA NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 33 NORTH AMERICA DEVICES IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 34 NORTH AMERICA DEVICES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 35 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 36 NORTH AMERICA ORAL IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 37 NORTH AMERICA PARENTERAL IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 38 NORTH AMERICA NASAL SPRAYS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 39 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 40 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 41 NORTH AMERICA PRESCRIPTION IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 42 NORTH AMERICA OVER THE COUNTER IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 43 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 44 NORTH AMERICA GENERIC IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 45 NORTH AMERICA BRANDED IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 46 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA HOSPITALS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 48 NORTH AMERICA CLINICS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 49 NORTH AMERICA HOMECARE IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 50 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 51 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 52 NORTH AMERICA HOSPITAL PHARMACIES IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 53 NORTH AMERICA RETAIL PHARMACIES IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 54 NORTH AMERICA ONLINE PHARMACIES IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 55 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 56 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 57 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TYPES OF MIGRAINE, 2018-2027 (USD MILLION)
TABLE 58 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 59 NORTH AMERICA ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 60 NORTH AMERICA NONSPECIFIC THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 61 NORTH AMERICA TRIPTANS IN MIGRAINE TREATMENT MARKET, BY TREATMENT , 2018-2027 (USD MILLION)
TABLE 62 NORTH AMERICA OPIATES/OPOIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 63 NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 64 NORTH AMERICA ERGOT ALKALOID IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 65 NORTH AMERICA ANTI-NAUSEA IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 66 NORTH AMERICA ADJUNCTIVE THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 67 NORTH AMERICA OTHERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 68 NORTH AMERICA PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 69 NORTH AMERICA ANTICONVULSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 70 NORTH AMERICA CALCITONIN GENE-RELATED PEPTIDE THERAPY IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 71 NORTH AMERICA SELECTIVE SEROTONIN RECEPTOR AGONISTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 72 NORTH AMERICA ANTIDEPRESSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 73 NORTH AMERICA NSAIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 74 NORTH AMERICA BLOOD PRESSURE-LOWERING MEDICATIONS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 75 NORTH AMERICA BETA BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 76 NORTH AMERICA CALCIUM-CHANNEL BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 77 NORTH AMERICA ANGIOTENSIN BLOCKERS: ACE-IS/ARBS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 78 NORTH AMERICA NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 79 NORTH AMERICA DEVICES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 80 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 81 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 82 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 83 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 84 NORTH AMERICA MIGRAINE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 85 U.S. MIGRAINE TREATMENT MARKET, BY TYPES OF MIGRAINE, 2018-2027 (USD MILLION)
TABLE 86 U.S. MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 87 U.S. ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 88 U.S. NONSPECIFIC THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 89 U.S. TRIPTANS IN MIGRAINE TREATMENT MARKET, BY TREATMENT , 2018-2027 (USD MILLION)
TABLE 90 U.S. OPIATES/OPOIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 91 U.S. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 92 U.S. ERGOT ALKALOID IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 93 U.S. ANTI-NAUSEA IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 94 U.S. ADJUNCTIVE THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 95 U.S. OTHERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 96 U.S. PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 97 U.S. ANTICONVULSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 98 U.S. CALCITONIN GENE-RELATED PEPTIDE THERAPY IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD)
TABLE 99 U.S. SELECTIVE SEROTONIN RECEPTOR AGONISTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 100 U.S. ANTIDEPRESSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 101 U.S. NSAIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 102 U.S. BLOOD PRESSURE-LOWERING MEDICATIONS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 103 U.S. BETA BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 104 U.S. CALCIUM-CHANNEL BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 105 U.S. ANGIOTENSIN BLOCKERS: ACE-IS/ARBS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 106 U.S. NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 107 U.S. DEVICES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 108 U.S. MIGRAINE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 109 U.S. MIGRAINE TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 110 U.S. MIGRAINE TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 111 U.S. MIGRAINE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 112 U.S. MIGRAINE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 113 CANADA MIGRAINE TREATMENT MARKET, BY TYPES OF MIGRAINE, 2018-2027 (USD MILLION)
TABLE 114 CANADA MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 115 CANADA ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 116 CANADA NONSPECIFIC THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 117 CANADA TRIPTANS IN MIGRAINE TREATMENT MARKET, BY TREATMENT , 2018-2027 (USD MILLION)
TABLE 118 CANADA OPIATES/OPOIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 119 CANADA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 120 CANADA ERGOT ALKALOID IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 121 CANADA ANTI-NAUSEA IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 122 CANADA ADJUNCTIVE THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 123 CANADA OTHERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 124 CANADA PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 125 CANADA ANTICONVULSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 126 CANADA CALCITONIN GENE-RELATED PEPTIDE THERAPY IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 127 CANADA SELECTIVE SEROTONIN RECEPTOR AGONISTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 128 CANADA ANTIDEPRESSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 129 CANADA NSAIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 130 CANADA BLOOD PRESSURE-LOWERING MEDICATIONS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 131 CANADA BETA BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 132 CANADA CALCIUM-CHANNEL BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 133 CANADA ANGIOTENSIN BLOCKERS: ACE-IS/ARBS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 134 CANADA NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 135 CANADA DEVICES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 136 CANADA MIGRAINE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 137 CANADA MIGRAINE TREATMENT MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 138 CANADA MIGRAINE TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 139 CANADA MIGRAINE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 140 CANADA MIGRAINE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 141 MEXICO MIGRAINE TREATMENT MARKET, BY TYPES OF MIGRAINE, 2018-2027 (USD MILLION)
TABLE 142 MEXICO MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 143 MEXICO ACUTE/ABORTIVE TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 144 MEXICO NONSPECIFIC THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 145 MEXICO TRIPTANS IN MIGRAINE TREATMENT MARKET, BY TREATMENT , 2018-2027 (USD MILLION)
TABLE 146 MEXICO OPIATES/OPOIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 147 MEXICO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 148 MEXICO ERGOT ALKALOID IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 149 MEXICO ANTI-NAUSEA IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 150 MEXICO ADJUNCTIVE THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 151 MEXICO OTHERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 152 MEXICO PREVENTIVE/PROPHYLACTIC TREATMENT IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 153 MEXICO ANTICONVULSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 154 MEXICO CALCITONIN GENE-RELATED PEPTIDE THERAPY IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 155 MEXICO SELECTIVE SEROTONIN RECEPTOR AGONISTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 156 MEXICO ANTIDEPRESSANTS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 157 MEXICO NSAIDS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 158 MEXICO BLOOD PRESSURE-LOWERING MEDICATIONS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 159 MEXICO BETA BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 160 MEXICO CALCIUM-CHANNEL BLOCKERS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 161 MEXICO ANGIOTENSIN BLOCKERS: ACE-IS/ARBS IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 162 MEXICO NON-PHARMACOLOGICAL THERAPIES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 163 MEXICO DEVICES IN MIGRAINE TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 164 MEXICO MIGRAINE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 165 MEXICO MIGRAINE TREATMENT MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 166 MEXICO MIGRAINE TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 167 MEXICO MIGRAINE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 168 MEXICO MIGRAINE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 169 SUBSIDIARIES OF JANSSEN NORTH AMERICA SERVICES, LLC

LIST OF FIGURE

LIST OF FIGURES
FIGURE 1 NORTH AMERICA MIGRAINE TREATMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA MIGRAINETREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA MIGRAINE TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA MIGRAINE TREATMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA MIGRAINE TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA MIGRAINE TREATMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA MIGRIANE TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA MIGRIANE TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA MIGRIANE TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA MIGRAINE TREATMENT MARKET
FIGURE 11 RESULT OF PREVALENCE OF MIGRAINE FROM ONE YEAR STUDY
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA MIGRIANE TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 13 INCREASING PREVALNCE OF MIGRAINE AND DEVELOPMENT OF NOVEL DRUGS IS DRIVING THE NORTH AMERICA MIGRIANE TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 14 EPISODIC IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MIGRAINE TREATMENT MARKET IN 2020 & 2027
FIGURE 15 NORTH AMERICA PREVALENCE OF MIGRAINE TREATMENT (2018)
FIGURE 16 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPES OF MIGRAINE, 2019
FIGURE 17 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPES OF MIGRAINE, 2019-2027 (USD MILLION)
FIGURE 18 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPES OF MIGRAINE, CAGR (2020-2027)
FIGURE 19 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPES OF MIGRAINE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TREATMENT, 2019
FIGURE 21 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
FIGURE 22 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TREATMENT, CAGR (2020-2027)
FIGURE 23 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 24 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2019
FIGURE 25 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
FIGURE 26 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2027)
FIGURE 27 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 28 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY PRODUCT TYPE, 2019
FIGURE 29 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY PRODUCT TYPE, 2019-2027 (USD MILLION)
FIGURE 30 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY PRODUCT TYPE, CAGR (2020-2027)
FIGURE 31 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPE, 2019
FIGURE 33 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPE, 2019-2027 (USD MILLION)
FIGURE 34 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPE, CAGR (2020-2027)
FIGURE 35 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 36 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY END USER, 2019
FIGURE 37 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY END USER, 2019-2027 (USD MILLION)
FIGURE 38 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY END USER, CAGR (2020-2027)
FIGURE 39 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019
FIGURE 41 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
FIGURE 42 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
FIGURE 43 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 NORTH AMERICA MIGRAINE TREATMENT MARKET: SNAPSHOT (2019)
FIGURE 45 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY COUNTRY (2019)
FIGURE 46 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY COUNTRY (2020 & 2027)
FIGURE 47 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY COUNTRY (2019 & 2027)
FIGURE 48 NORTH AMERICA MIGRAINE TREATMENT MARKET: BY TYPES OF MIGRAINE (2020-2027)
FIGURE 49 NORTH AMERICA MIGRAINE TREATMENT MARKET: COMPANY SHARE 2019 (%)